EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Type I interferon signalling and interferon‐responsive microglia in health and disease

Jose P Lopez-Atalaya iD, Aysha M Bhojwani-Cabrera

The FEBS Journal · 2025-11 · 292 (22) · 5921-5940

DOI: 10.1111/febs.70126 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 29.04.2025. Verfasst von Jose P Lopez-Atalaya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas, Universidad Miguel Hernández, Alicante, Spain. Hauptthemen laut MEDLINE: Microglia, Interferon Type I, Signal Transduction, Neurodegenerative Diseases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MCIU/AEI/10.13039/501100011033, Generalitat Valenciana.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent evidence suggests that type I interferon (IFN‐I) signalling extends beyond its canonical roles in antiviral defence and immunomodulation. Over the past decade, dysregulated IFN‐I signalling has been linked to genetic disorders and neurodegenerative diseases, where it may contribute to neurological impairments. Microglia have emerged as key mediators of IFN‐I responses in the central nervous system. A distinct transcriptional state responsive to interferons has recently been identified in microglia. The activation of the IFN‐I pathway in these cells is now recognised as pivotal in both development and neurodegeneration. This review is divided into two main sections: the first examines the broader role of IFN‐I signalling in the central nervous system, particularly its contribution to neurological dysfunction; the second focuses on the specific state of interferon‐responsive microglia, exploring its mechanisms and relevance in neurodegenerative conditions. Finally, we discuss how these areas intersect and their implications for both healthy and diseased states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaInterferon Type ISignal TransductionNeurodegenerative DiseasesHumansAnimalsCentral Nervous System

Stichwörter der Autor:innen

braininterferon‐responsive microgliamicroglianeuroinflammationtype‐I interferon

Substanzen

Interferon Type I

Autor:innen und Institutionen

  • Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas, Universidad Miguel Hernández, Alicante, Spain.

ORCID-Profile: Jose P Lopez-Atalaya

Förderung

  • MCIU/AEI/10.13039/501100011033
  • Generalitat Valenciana

Zitieren

APA

Lopez-Atalaya, J. P., & Bhojwani-Cabrera, A. M. (2025). Type I interferon signalling and interferon‐responsive microglia in health and disease. The FEBS Journal, 292(22), 5921-5940. https://doi.org/10.1111/febs.70126

Vancouver

Lopez-Atalaya JP, Bhojwani-Cabrera AM. Type I interferon signalling and interferon‐responsive microglia in health and disease. The FEBS Journal. 2025;292(22):5921-5940. doi:10.1111/febs.70126

BibTeX
@article{LopezAtalaya2025,
  author = {Lopez-Atalaya, Jose P and Bhojwani-Cabrera, Aysha M},
  title = {Type I interferon signalling and interferon‐responsive microglia in health and disease},
  journal = {The FEBS Journal},
  year = {2025},
  volume = {292},
  number = {22},
  pages = {5921--5940},
  doi = {10.1111/febs.70126}
}
Kostenlos starten →